New pharmaceutical product development: Barriers to overcome and opportunities to exploit

Journal of Commercial Biotechnology

Volumn 14, Issue 3, 2008, Pages 201-212

  Terblanche, Nic S ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CHEMOTHERAPY; CLIMATE CHANGE; DRUG DELIVERY; DRUG DOSAGE; DRUG PRODUCTS PLANTS; INDUSTRY; KETONES; MARKETING; PRODUCT DEVELOPMENT; PROJECT MANAGEMENT; TECHNOLOGY;

(OTDR) TECHNOLOGY; BIOTECHNOLOGY INDUSTRIES; HIGH COSTS; NEW APPROACHES; OFF SHORING; PARTNER (CO); PHARMACEUTICAL INDUSTRIES; PRODUCT INNOVATION MANAGEMENT; RATE OF INCREASE; STATE OF AFFAIRS;

CHEMICALS;

NEW DRUG;

ARTICLE; BIOTECHNOLOGICAL PRODUCTION; CLIMATE CHANGE; COST; DRUG INDUSTRY; DRUG MARKETING; GOVERNMENT REGULATION; GREENHOUSE EFFECT; INFORMATION TECHNOLOGY; INVESTMENT; PATENT; PRODUCT DEVELOPMENT;

EID: 46649089334     PISSN: 14628732     EISSN: None     Source Type: Journal    
DOI: 10.1057/jcb.2008.11     Document Type: Article

References (34)

1. Ho, R. J. Y. & Gibaldi, M. (2003). Biotechnology and Biopharmaceuticals: Transforming Proteins and Genes, Wiley, Hoboken, NJ, p. 576.
2. Pharma (2010). The threshold of innovation, http://www-935.ibm.com/ services/de/bcs/pdf/2006/pharma_2010.pdf, IBM Global Business Services (accessed 13th January, 2008).
3. Gupta, A., Pawar, K. S. & Smart, P. (2007). New product development in the pharmaceutical and telecommunications industries: A comparative study. Int. J. Prod. Econ. 160, 41-60.
4. PricewaterhouseCoopers Health Research Institute (2008). Top eight health industry issues in 2008, http://pwchealth.com/cgi-local/ hregister.cgi?link=reg/top8issues.pdf (accessed 11th January, 2008).
5. IMS Health (2001). World Review 2001: The Pharmaceutical Market, IMS Health Inc, Norwalk, Connecticut, p. 32.
6. Javalgi, R. G. & Wright, R. F. (2003). An international market entry model for pharmaceutical companies: A conceptual; framework for strategic decisions. Int. J. Med. Mkt. 3, 274-286.
7. Takeuchi, H. & Nonaka, I. (1986). The new new product development game. Harv. Bus. Rev. 64, 137-146.
8. Bernstein, A. (2008). Making Innovation Strategy Succeed. A Strategy + Business Exclusive, Booz Allen Hamilton, New York.
9. Venter, G. H. C. (2001). The application of new product development principles in the pharmaceutical industry. A comparative study of marketing practitioners' perceptions', Unpublished MComm assignment, Department of Business Management, University of Stellenbosch.
10. Lamb, C. W., Hair, J. F., McDaniel, C., Boshoff, C. & Terblanche, N. S. (2004). Marketing, Oxford, Cape Town, p. 254.
11. PricewaterhouseCoopers (2007). Pharma 2020: The Vision, PricewaterhouseCoopers, London.
12. DiMasi, J. A., Hansen, R. W. & Grabowski, H. G. (2003). The price of innovation: New estimates of drug development costs. J. Health Econ. 22, 151-185.
13. Kola, I. & Landis, J. (2004). Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Disc. 3, 711-715.
14. Federal Drug Administration (2004). Innovation or Stagnation. Challenge and Opportunity on the Critical Path to New Medicinal Products Department of Health and Human Services, Rockville.
15. Hansen, R. W. (1979). The pharmaceutical development process: Estimates of current development costs and times and the effects of regulatory changes, in Chien, R.I. (ed.), Issues in Pharmaceutical Economics, Lexington Books, Lexington, MA, pp. 151-187.
16. DiMasi, J. A., Hansen, R. W., Grabowski, H. G. & Lasagna, L. (1991). Cost of innovation in the pharmaceutical industry. J. Health Econ. 10, 107-142.
17. Skrepnek, G. H. & Sarnowski, J. J. (2007). Decision-making associated with drug candidates in the biotechnology research and development (R&D) pipeline. J. Com. Biol. 13, 99-110.
18. Balas, E. A. & Boren, S. A. (2000). Managing clinical knowledge for health care improvement. Yearbook Med. Info. 9, 65-70.
19. PricewaterhouseCoopers Health Research Institute and Montagne Group (2008). Creating a climate of innovation: The industry's most challenging paradox, http://pwchealth.com/cgi-local/hregister.cgi?link= reg/pubclimateinnovation.pdf (accessed on 11th January, 2008).
20. James, B. G. (2006). Pharma Marketing ROI, Report on the eyeforpharma 6th Annual European Pharmaceutical Congress. Amsterdam, October 23-24.
21. Grabowski, H., Vernon, J. & DiMasi, J. (2002). Returns on research and development for 1990s new drug introductions. PharmoEcon 20 (3), 11-29.
22. PricewaterhouseCoopers Health Research Institute (2008). Recapturing the vision: Restoring trust in the pharmaceutical industry by translating expectations into actions, http://www.pwc.com/extweb/ pwcpublications.nsf/docid/e8a194168c19de678525726100550b91 (accessed 13th January, 2008).
23. The Association of the British Pharmaceutical Industry (2008). New Code of practice for pharmaceutical industry revealed, http://www.abpi.org.uk/press/press_releases_05/051116b.asp (accessed 10th January, 2008).
24. Snow, R. W., Guerra, C. A., Noor, A. N., Myint, H. Y. & Hay, S. I. (2005). The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434, 214-217.
25. WHO (2003). Africa malaria report, WHO, Geneva, Switzerland.
26. Harvard Medical School (2005). Climate Change Futures. Health, Ecological and Economic Dimensions, The Center for health and the Global Environment, Boston, MA, p. 138.
27. MacArthur, R. H. (1972). Geographical Ecology: Patterns in the Distribution of Species, Harper & Row, New York.
28. Githeko, A. K. & Ndegwa, W. (2001). Predicting malaria epidemics in the Kenyan highlands using climate data: A tool for decision makers. Glob Change Hum. Hlth. 2, 54-63.
29. Greenwood, B. & Mutabingwa, T. (2002). Malaria in 2002. Nature 415, 670-672.
30. McMichael, A. J., Haines, A., Slooff, R. & Kovats, S. (1996). Climate Change and Human Health, WHO, World Meteorological Organization, UN Environmental Programme, Geneva.
31. Vanderbyl, S. & Kobelak, S. (2007). Critical success factors for biotechnology industry in Canada. J. Com. Biol. 13, 68-77.
32. Bloch, M., Dhankhar, A. & Narayanan, S. (2006). Pharma leaps offshore. McKinsey & Company. Inno. IT Mngi. 7, 12-19.
33. Marhawa, S. & Van Kuiken, S. J. (2005). The changing role of IT in pharma. McKinsey on IT. Inno. IT Mngt. 6, 2-9.
34. Marhawa, S., Patil, S. & Singh, N. (2007). Using IT to speed up clinical trials. McKinsey & Company. Inno. IT Mngt 8, 12-19.